An open-label, randomised study of dihydroartemisinin-piperaquine versus artesunate-mefloquine for falciparum malaria in Asia.

BACKGROUND: The artemisinin-based combination treatment (ACT) of dihydroartemisinin (DHA) and piperaquine (PQP) is a promising novel anti-malarial drug effective against multi-drug resistant falciparum malaria. The aim of this study was to show non-inferiority of DHA/PQP vs. artesunate-mefloquine (...

Deskribapen osoa

Xehetasun bibliografikoak
Egile Nagusiak:	Valecha, N, Phyo, A, Mayxay, M, Newton, P, Krudsood, S, Keomany, S, Khanthavong, M, Pongvongsa, T, Ruangveerayuth, R, Uthaisil, C, Ubben, D, Duparc, S, Bacchieri, A, Corsi, M, Rao, B, Bhattacharya, P, Dubhashi, N, Ghosh, S, Dev, V, Kumar, A, Pukrittayakamee, S, Pukittayakamee, S
Formatua:	Journal article
Hizkuntza:	English
Argitaratua:	Public Library of Science 2010

An open-label, randomised study of dihydroartemisinin-piperaquine versus artesunate-mefloquine for falciparum malaria in Asia nork Valecha, N, Phyo, A, Mayxay, M, Newton, P, Krudsood, S, Keomany, S, Khanthavong, M, Pongvongsa, T, Ruangveerayuth, R, Uthaisil, C, Ubben, D, Duparc, S, Bacchieri, A, Corsi, M, Rao, B, Bhattacharya, P, Dubhashi, N, Ghosh, S, Dev, V, Kumar, A, Pukrittayakamee, S

Argitaratua 2010

Journal article

An open-label, randomised study of dihydroartemisinin-piperaquine versus artesunate-mefloquine for falciparum malaria in Asia.

Antzeko izenburuak